The introduction of an ICD-10 code specific to IgG4-Related Disease offers a promising opportunity to revolutionize patient care, enable more accurate diagnoses, and improve outcomes.
In this episode of MEDcast, Dr Julia Blanchette joins Diana Isaacs, PharmD, BC-ADM, CDCES, and Natalie Bellini, DNP, FNP-BC, discuss strategies to empower young adults with the skills and resources necessary to effectively manage type 1 diabetes and maintain a healthy lifestyle.
Expert endocrinologists provide final thoughts on addressing unmet needs and improving the management of T1D.
The US and the world must appreciate the role of the pharmaceutical industry who are rescuing the world from COVID-19—the medical breakthrough of our lifetime.
Experts in gastroenterology discuss treatment selection in special situations of CD, such as age, women considering pregnancy, and extra-intestinal manifestations.
Satralizumab represents only the second targeted treatment for NMOSD and the first cleared for at-home administration.
A panel of eye care specialists share clinical advice and future directions for the treatment of wet AMD.
An expert panel discusses where bempedoic acid currently fits into the treatment of hypercholesterolemia.
A panel of eye care specialists share clinical advice and future directions for the treatment of wet AMD.
Closing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.
Dhiren Patel, PharmD, and Bob Busch, MD, interview Fatima Cody Stanford, MD, MPH, MPA, an obesity medicine specialist, to examine the cardiovascular (CV) impact of obesity and delve into the potential benefits of newer weight loss medications in mitigating CV risk and heart failure.
Dr Taub describes effective strategies in overcoming access barriers to novel lipid lowering therapies.
Eiran Gorodeski, MD, MPH, Parag Goyal, MD, MSc, and James Fang, MD, discuss the HFSA's recent scientific statement on the prevalence and impact of cognitive impairment on the management of heart failure.
Jayme Heim, MSN, FNP-BC, and Matthew T. Reynolds, PA-C, shares clinical pearls for clinicians managing patients with plaque psoriasis.
Dr. Woolery-Lloyd shares her advice for vitiligo providers and tips for helpful communication with patients.
Dermatological experts discuss challenges that are associated with the use of standard and emerging treatments in special patient population.
Expert hepatologists discuss future developments in HCV that they are excited about and provide resources for new providers to get started on delivering HCV care.
This publication was developed independently by MJH Life Sciences Global Medical Affairs. Support for the thought leaders meeting and the publication was provided by Arcutis Biotherapeutics, Inc; The Bristol Myers Squibb Company; Janssen Global Services, LLC; and UCB, Inc.
Drs James Januzzi, Javed Butler, Robert Mentz, and Muthiah Vaduganathan share practice pearls for treating patients with heart failure, focusing on the future of treatment.
New research suggests use of reduced-dose CT scans could be as effective and reduce the need for re-imaging.
Andrew Wang, MD; James Januzzi, MD; Michelle M. Kittleson, MD, PhD; and Milind Desai, MD, MBA, share a look into the future of oHCM treatment.
Ophthalmologist experts provide an overview of emerging treatments for dry eye disease.
A panel of expert cardiologists share their concluding thoughts on management of polyvascular disease in clinical practice.
In this episode of MEDcast, Diana Isaacs and Natalie Bellini interview Dr. Ken Fujioka, an endocrine specialist, to discuss practice guidelines on obesity treatment and the evolution of anti-obesity medications over the last decade.
A panel of experts in schizophrenic psychiatric care share their thoughts on the practice, patients, and treatment based on their years of experience.